Search

Author/Creator Arends, Eline J

1. Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results. Issue 8 (27th June 2020)

Authors:
Kraaij, Tineke; Arends, Eline J; van Dam, Laura S; Kamerling, Sylvia W A; van Daele, Paul L A; Bredewold, Obbo W; Ray, Argho; Bakker, Jaap A; Scherer, Hans U; Huizinga, Tom J W; Rabelink, Ton J; van Kooten, Cees; Teng, Y K Onno
Journal:
Nephrology dialysis transplantation
Issue:
Volume 36:Issue 8(2021)
Page Start:
1474
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. MO246: Belimumab Disrupts Memory B Cell Trafficking in Patients with Systemic Lupus Erythematosus. (3rd May 2022)

Authors:
Arends, Eline J; Zlei, Mihaela; Tipton, Christopher M; Osmani, Zgjim; de Bie, Fenna; Kamerling, Sylvia W A; Rabelink, Ton; Sanz, Ignacio; Van Dongen, Jacques J M; van Kooten, Cees; Teng, Yeo K O
Journal:
Nephrology dialysis transplantation
Issue:
Volume 37(2022)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P127 Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory SLE: two year results rituximab and belimumab combination for severe SLE. (23rd March 2020)

Authors:
Kraaij, Tineke; Arends, Eline J; van Dam, Laura S; Kamerling, Sylvia WA; Daele, Paul LA van; Bredewold, Obbo W; Ray, Argho; Bakker, Jaap A; Scherer, Hans U; Huizinga, Tom JW; Rabelink, Ton J; Kooten, Cees van; Teng, YK Onno
Journal:
Lupus science & medicine
Issue:
Volume 7(2020)Supplement 1
Page Start:
A90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗